Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL), is a leader in inhaled anesthetics and a global player in hospital generics. The company's vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders, drives its operations. With a wide presence across the US, Europe, and more than 100 countries globally, PCC's product portfolio includes various critical care solutions such as inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and oral therapy for specific diseases. boasting fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India, the company emphasizes customer centricity as a cornerstone of its business. PCC's focus on manufacturing and process development experience further solidifies its position in the market. It is essential to report any adverse effects of PCC products to [email protected].
There is no investment information
No recent news or press coverage available for Piramal Critical Care.